Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Abroad (travel likely)Recruiting

Conditions

Oral Cancer · Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NYU College of Dentistry, New York, New York, United States
Contact: Study coordinator (Yatendra Mulpuri, PhD) · ym2891@nyu.edu · 424-230-4222
Contact: Study coordinator (Mariana Bucovsky, MHA) · mb10357@nyu.edu · 212-998-9389
Contact: Principal Investigator (Brian L Schmidt, DDS)

Study leads

Brian L Schmidt, DDS
Principal Investigator
NYU College of Dentistry

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma · Hypopharyngeal Squamous Cell Carcinoma · Laryngeal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Irvine, United States · Orange, United States

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Glioblastoma Multiforme (GBM) · Glioblastoma · Glioma of Brain

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Oral Cancer

Abroad (travel likely)Recruiting

Milwaukee, United States